Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma

25 Sept 2015

Abstract excerpt

// Hong-Xia Zhang 1, 2 , Shan-Shan Jiang 1, 2 , Xiao-Fei Zhang 1, 2 , Zi-Qi Zhou 1, 2 , Qiu-Zhong Pan 1, 2 , Chang-Long Chen 1, 2 , Jing-Jing Zhao 1, 2 , Yan Tang 1, 2 , Jian-Chuan Xia 1, 2 , De-Sheng Weng 1, 2 1 Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China 2 Department of Biotherapy, Sun Yat-Sen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Endoplasmic Reticulum Stress and Disease
Share to Ubiquitin and proteasome pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26430962
DOI: 10.18632/oncotarget.5470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinomaPMID 26430962Read ↗

Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma ManagementSemantic proximity Read ↗

Cyclin-Dependent Kinase Regulatory Subunit 2 Indicated Poor Prognosis and Facilitated Aggressive Phenotype of Hepatocellular Carcinoma.Semantic proximity Read ↗

The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsSemantic proximity Read ↗

Oncogenic potential of Cyclin Kinase Subunit‐2 in cholangiocarcinomaSemantic proximity Read ↗

CKS2 in human cancers: Clinical roles and current perspectives (Review)Semantic proximity Read ↗

CKS2 Predicts A Poor Prognosis and Contributes to Malignant Progression of Pancreatic CancerSemantic proximity Read ↗

Biological functions and therapeutic potential of CKS2 in human cancerSemantic proximity Read ↗

Mining CK2 in CancerSemantic proximity Read ↗

Therapeutic targeting of CK2 in acute and chronic leukemiasSemantic proximity Read ↗

Protein Kinase CK2α Maintains Extracellular Signal-regulated Kinase (ERK) Activity in a CK2α Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but Not ERK in BRAF Mutant Melanoma.Semantic proximity Read ↗

Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinomaSemantic proximity Read ↗

Therapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.